Specialty Growth Should Be Measured by Completion, Not Just Referrals
A practical performance lens for specialty programs. Practical guidance for independent pharmacy owners tracking specialty pharmacy referral completion.
May 22, 2026 / 5 min readDispense Times Intelligence
Reporting, analysis, and partner resources for independent pharmacy decision makers.
A practical performance lens for specialty programs. Practical guidance for independent pharmacy owners tracking specialty pharmacy referral completion.
May 22, 2026 / 5 min read
Why advanced therapy trends can affect local pharmacy conversations, expectations, and referral awareness. Practical guidance for independent pharmacy owners tracking cell and…
May 22, 2026 / 6 min read
A business-focused look at payer and access pressure in specialty pharmacy. Practical guidance for independent pharmacy owners tracking specialty pharmacy market access.
May 22, 2026 / 5 min read
Why biologic support depends on workflow, access, and patient communication. Practical guidance for independent pharmacy owners tracking biologic therapy pharmacy support.
May 22, 2026 / 5 min read
How clean intake documentation supports specialty operations and referral trust. Practical guidance for independent pharmacy owners tracking specialty pharmacy intake documentation.
May 22, 2026 / 5 min read
Specialty growth can look attractive, but pharmacies need intake discipline, documentation, payer awareness, and patient support before volume expands.
May 11, 2026 / 5 min read
As specialty therapies become more complex, pharmacy intake must become more structured, more documented, and more patient-centered.
May 11, 2026 / 5 min read
Specialty pharmacy leaders are watching convergence across advanced therapies, payer strategy, adherence, technology, and patient navigation.
May 10, 2026 / 7 min read